TRAF2 exerts opposing effects on basal and TNFα-induced activation of the classic IKK complex in hematopoietic cells in mice

Journal of Cell Science

Volumn 129, Issue 7, 2016, Pages 1455-1467

  Zhang, Laiqun ^a   Blackwell, Ken ^a   Workman, Lauren M ^a   Gibson Corley, Katherine N ^a   Olivier, Alicia K ^a   Bishop, Gail A ^a   Habelhah, Hasem ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Apoptosis; NF B; TNF ; TRAF2; TRAF5

Indexed keywords

CASPASE 8; I KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEIN 1; INHIBITOR OF APOPTOSIS PROTEIN 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 5; BIRC2 PROTEIN, MOUSE; BIRC3 PROTEIN, MOUSE; CCL5 PROTEIN, MOUSE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INHIBITOR OF APOPTOSIS PROTEIN; NOS2 PROTEIN, MOUSE; RANTES; TUMOR NECROSIS FACTOR; UBIQUITIN PROTEIN LIGASE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; BRADYPNEA; CONTROLLED STUDY; DIARRHEA; ENZYME ACTIVATION; FETUS; GENE EXPRESSION; GENE INDUCTION; HEMATOPOIETIC CELL; LIVER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SPLEEN; ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; C57BL MOUSE; CELL CULTURE; DEFICIENCY; GENETICS; KNOCKOUT MOUSE; METABOLISM;

ANIMALS; APOPTOSIS; CASPASE 8; CELLS, CULTURED; CHEMOKINE CCL5; ENZYME ACTIVATION; I-KAPPA B KINASE; INHIBITOR OF APOPTOSIS PROTEINS; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; TNF RECEPTOR-ASSOCIATED FACTOR 2; TNF RECEPTOR-ASSOCIATED FACTOR 5; TUMOR NECROSIS FACTOR-ALPHA; UBIQUITIN-PROTEIN LIGASES;

EID: 84964045814     PISSN: 00219533     EISSN: 14779137     Source Type: Journal    
DOI: 10.1242/jcs.180554     Document Type: Article

References (41)

1. Alvarez, S. E., Harikumar, K. B., Hait, N. C., Allegood, J., Strub, G. M., Kim, E. Y., Maceyka, M., Jiang, H., Luo, C., Kordula, T. et al. (2010). Sphingosine-1-phosphate is a missing cofactor for the E3 ubiquitin ligase TRAF2. Nature 465, 1084-1088.
2. Blackwell, K., Zhang, L., Workman, L. M., Ting, A. T., Iwai, K. and Habelhah, H. (2013). Two coordinated mechanisms underlie tumor necrosis factor alpha-induced immediate and delayed IkappaB kinase activation. Mol. Cell. Biol. 33, 1901-1915.
3. Bonizzi, G. and Karin, M. (2004). The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol. 25, 280-288.
4. Bradley, J. R. and Pober, J. S. (2001). Tumor necrosis factor receptor-associated factors (TRAFs). Oncogene 20, 6482-6491.
5. Budd, R. C., Yeh, W.-C. and Tschopp, J. (2006). cFLIP regulation of lymphocyte activation and development. Nat. Rev. Immunol. 6, 196-204.
6. Chen, Z. J. and Sun, L. J. (2009). Nonproteolytic functions of ubiquitin in cell signaling. Mol. Cell 33, 275-286.
7. Csomos, R. A., Brady, G. F. and Duckett, C. S. (2009). Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2. J. Biol. Chem. 284, 20531-20539.
8. Feltham, R., Moulin, M., Vince, J. E., Mace, P. D., Wong, W. W. L., Anderton, H., Day, C. L., Vaux, D. L. and Silke, J. (2010). Tumor necrosis factor (TNF) signaling, but not TWEAK (TNF-like weak inducer of apoptosis)-triggered cIAP1 (cellular inhibitor of apoptosis protein 1) degradation, requires cIAP1 RING dimerization and E2 binding. J. Biol. Chem. 285, 17525-17536.
9. Haas, T. L., Emmerich, C. H., Gerlach, B., Schmukle, A. C., Cordier, S. M., Rieser, E., Feltham, R., Vince, J., Warnken, U., Wenger, T. et al. (2009). Recruitment of the linear ubiquitin chain assembly complex stabilizes the TNF-R1 signaling complex and is required for TNF-mediated gene induction. Mol. Cell 36, 831-844.
10. Habelhah, H. (2010). Emerging complexity of protein ubiquitination in the NF-kappaB pathway. Genes Cancer 1, 735-747.
11. Habelhah, H., Takahashi, S., Cho, S.-G., Kadoya, T., Watanabe, T. and Ronai, Z. (2004). Ubiquitination and translocation of TRAF2 is required for activation of JNK but not of p38 or NF-kappaB. EMBO J. 23, 322-332.
12. Hayden, M. S. and Ghosh, S. (2008). Shared principles in NF-kappaB signaling. Cell 132, 344-362.
13. Hochstedler, C. M., Leidinger, M. R., Maher-Sturm, M. T., Gibson-Corley, K. N. and Meyerholz, D. K. (2013). Immunohistochemical detection of arginase-I expression in formalin-fixed lung and other tissues. J. Histotechnol. 36, 128-134.
14. Hoffmann, A., Levchenko, A., Scott, M. L. and Baltimore, D. (2002). The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation. Science 298, 1241-1245.
15. Hoffmann, A., Leung, T. H. and Baltimore, D. (2003). Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 22, 5530-5539.
16. Iwai, K. and Tokunaga, F. (2009). Linear polyubiquitination: a new regulator of NF-kappaB activation. EMBO Rep. 10, 706-713.
17. Kraus, Z. J., Haring, J. S. and Bishop, G. A. (2008). TNF receptor-associated factor 5 is required for optimal T cell expansion and survival in response to infection. J. Immunol. 181, 7800-7809.
18. Lee, T. H., Shank, J., Cusson, N. and Kelliher, M. A. (2004). The kinase activity of Rip1 is not required for tumor necrosis factor-alpha-induced IkappaB kinase or p38 MAP kinase activation or for the ubiquitination of Rip1 by Traf2. J. Biol. Chem. 279, 33185-33191.
19. Lin, W.-J., Su, Y.-W., Lu, Y.-C., Hao, Z., Chio, I. I., Chen, N.-J., Brustle, A., Li, W. Y. and Mak, T.W. (2011). Crucial role for TNF receptor-associated factor 2 (TRAF2) in regulating NF-kappaB2 signaling that contributes to autoimmunity. Proc. Natl. Acad. Sci. USA 108, 18354-18359.
20. Mahoney, D. J., Cheung, H. H., Mrad, R. L., Plenchette, S., Simard, C., Enwere, E., Arora, V., Mak, T.W., Lacasse, E. C., Waring, J. et al. (2008). Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation. Proc. Natl. Acad. Sci. USA 105, 11778-11783.
21. Nakajima, A., Komazawa-Sakon, S., Takekawa, M., Sasazuki, T., Yeh, W.-C., Yagita, H., Okumura, K. and Nakano, H. (2006). An antiapoptotic protein, c-FLIPL, directly binds to MKK7 and inhibits the JNK pathway. EMBO J. 25, 5549-5559.
22. Nguyen, L. T., Duncan, G. S., Mirtsos, C., Ng, M., Speiser, D. E., Shahinian, A., Marino, M. W., Mak, T. W., Ohashi, P. S. and Yeh, W.-C. (1999). TRAF2 deficiency results in hyperactivity of certain TNFR1 signals and impairment of CD40-mediated responses. Immunity 11, 379-389.
23. Okazaki, T., Sakon, S., Sasazuki, T., Sakurai, H., Doi, T., Yagita, H., Okumura, K. and Nakano, H. (2003). Phosphorylation of serine 276 is essential for p65 NF-kappaB subunit-dependent cellular responses. Biochem. Biophys. Res. Commun. 300, 807-812.
24. Tada, K., Okazaki, T., Sakon, S., Kobarai, T., Kurosawa, K., Yamaoka, S., Hashimoto, H., Mak, T.W., Yagita, H., Okumura, K. et al. (2001). Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-kappa B activation and protection from cell death. J. Biol. Chem. 276, 36530-36534.
25. Varfolomeev, E., Blankenship, J.W., Wayson, S. M., Fedorova, A. V., Kayagaki, N., Garg, P., Zobel, K., Dynek, J. N., Elliott, L. O., Wallweber, H. J. et al. (2007). IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis. Cell 131, 669-681.
26. Varfolomeev, E., Goncharov, T., Fedorova, A. V., Dynek, J. N., Zobel, K., Deshayes, K., Fairbrother, W. J. and Vucic, D. (2008). c-IAP1 and c-IAP2 are critical mediators of tumor necrosis factor alpha (TNFalpha)-induced NF-kappaB activation. J. Biol. Chem. 283, 24295-24299.
27. Ventura, J.-J., Kennedy, N. J., Lamb, J. A., Flavell, R. A. and Davis, R. J. (2003). c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol. Cell. Biol. 23, 2871-2882.
28. Vince, J. E., Wong, W. W.-L., Khan, N., Feltham, R., Chau, D., Ahmed, A. U., Benetatos, C. A., Chunduru, S. K., Condon, S. M., McKinlay, M. et al. (2007). IAP antagonists target cIAP1 to induce TNFalpha-dependent apoptosis. Cell 131, 682-693.
29. Vince, J. E., Pantaki, D., Feltham, R., Mace, P. D., Cordier, S. M., Schmukle, A. C., Davidson, A. J., Callus, B. A., Wong, W. W., Gentle, I. E. et al. (2009). TRAF2 must bind to cellular inhibitors of apoptosis for tumor necrosis factor (TNF) to efficiently activate NF-(kappa)B and to prevent tnf-induced apoptosis. J. Biol. Chem. 284, 35906-35915.
30. Wajant, H. and Scheurich, P. (2011). TNFR1-induced activation of the classical NF-kappaB pathway. FEBS J. 278, 862-876.
31. Wang, C. Y., Mayo, M. W., Korneluk, R. G., Goeddel, D. V. and Baldwin, A. S., Jr (1998). NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 281, 1680-1683.
32. Wang, L., Du, F. and Wang, X. (2008). TNF-alpha induces two distinct caspase-8 activation pathways. Cell 133, 693-703.
33. Wong, W.W.-L., Gentle, I. E., Nachbur, U., Anderton, H., Vaux, D. L. and Silke, J. (2010). RIPK1 is not essential for TNFR1-induced activation of NF-kappaB. Cell Death Differ. 17, 482-487.
34. Workman, L. M. and Habelhah, H. (2013). TNFR1 signaling kinetics: spatiotemporal control of three phases of IKK activation by posttranslational modification. Cell Signal. 25, 1654-1664.
35. Wu, C. J., Conze, D. B., Li, T., Srinivasula, S. M. and Ashwell, J. D. (2006). NEMO is a sensor of Lys 63-linked polyubiquitination and functions in NF-κB activation. Nat. Cell Biol. 8, 398-406.
36. Yamamoto, M., Okamoto, T., Takeda, K., Sato, S., Sanjo, H., Uematsu, S., Saitoh, T., Yamamoto, N., Sakurai, H., Ishii, K. J. et al. (2006). Key function for the Ubc13 E2 ubiquitin-conjugating enzyme in immune receptor signaling. Nat. Immunol. 7, 962-970.
37. Yeh, W.-C., Shahinian, A., Speiser, D., Kraunus, J., Billia, F., Wakeham, A., de la Pompa, J. L., Ferrick, D., Hum, B., Iscove, N. et al. (1997). Early lethality, functional NF-kappaB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 7, 715-725.
38. Yin, Q., Lamothe, B., Darnay, B. G. and Wu, H. (2009). Structural basis for the lack of E2 interaction in the RING domain of TRAF2. Biochemistry 48, 10558-10567.
39. Zarnegar, B., Yamazaki, S., He, J. Q. and Cheng, G. (2008). Control of canonical NF-kappaB activation through the NIK-IKK complex pathway. Proc. Natl. Acad. Sci. USA 105, 3503-3508.
40. Zhang, L., Blackwell, K., Thomas, G. S., Sun, S., Yeh, W.-C. and Habelhah, H. (2009). TRAF2 suppresses basal IKK activity in resting cells and TNFalpha can activate IKK in TRAF2 and TRAF5 double knockout cells. J. Mol. Biol. 389, 495-510.
41. Zhang, L., Blackwell, K., Shi, Z. and Habelhah, H. (2010). The RING domain of TRAF2 plays an essential role in the inhibition of TNFalpha-induced cell death but not in the activation of NF-kappaB. J. Mol. Biol. 396, 528-539.